SURG stock forecast, quote, news & analysis
Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels... Show more
Why SurgePays (SURG) Is Down -21% in the Last 30 Days
Key Takeaways
- SURG stock declined approximately -21% over the past 30 days amid broader market pressures and company-specific challenges like delayed filings.
- Over the past quarter, the stock fell around -67%, reflecting persistent losses despite revenue growth in prior quarters.
- Recent Q3 2025 earnings showed 292% YoY revenue surge to $18.7M but widened net losses to $7.5M and EPS miss, eroding investor confidence.
- Delayed 2025 10-K filing due to audit issues added uncertainty, contributing to downward price movement.
- Launch of stored value and loyalty platform signals fintech expansion, but operational inefficiencies and cash burn remain key drags.
- Microcap volatility and low trading volumes amplified the downtrend in a risk-off environment.
SurgePays (SURG) Company Overview and Market Position
SurgePays, Inc. (SURG) is a financial technology and telecom company specializing in mobile virtual network operator (MVNO) services and point-of-sale platforms. The company provides prepaid wireless top-ups, mobile broadband, and fintech solutions like ACH banking to convenience stores, targeting underserved and subprime consumers. Its core business model leverages a nationwide retail network to distribute wireless plans under brands like Torch Wireless (via the Lifeline government subsidy program) and LinkUp Mobile, alongside marketing and transaction services.
In the competitive fintech and telecom sectors, SURG differentiates through its integrated ecosystem serving independent retailers in rural areas, where traditional banking and connectivity gaps persist. However, thin margins in prepaid services and reliance on government programs expose it to operational risks, explaining recent stock price weakness despite revenue potential.
SurgePays (SURG) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, SURG stock dropped from a closing price of $0.85 on March 10, 2026, to $0.67 on April 10, 2026, a decline of -21%. The movement was volatile and range-bound, trading between $0.65 and $0.88, with steady downward pressure amid low volumes averaging under 100K shares daily.
For the past quarter, the stock plummeted -67% from $2.04 around January 12, 2026, to $0.67 currently. This trend-driven selloff accelerated in January-February, stabilizing briefly in March before resuming lower, influenced by earnings disappointments and filing delays.
What Drove SURG Stock Price in the Last 30 Days
The 30-day decline stemmed primarily from a delayed Form 10-K filing for fiscal 2025, announced March 31, 2026, due to audit completion issues. This raised concerns over financial transparency, pressuring the microcap stock in a cautious market.
While the April 2 launch of a stored value and loyalty platform across its retail network offered mild positivity, it failed to offset broader sentiment. No major analyst upgrades or sector tailwinds emerged, and thin liquidity amplified downside moves. Macro factors like interest rate uncertainty indirectly weighed on growth stocks like SURG.
What Drove SURG Stock Performance Over the Last Quarter
The quarterly -67% drop was dominated by Q3 2025 earnings on November 12, 2025, revealing a $7.5M net loss despite 292% revenue growth to $18.7M, driven by MVNO expansion. The EPS miss (-$0.38 vs. -$0.12 expected) highlighted gross losses ($2.6M) and cash burn to $2.5M, signaling scaling pains.
Institutional selling and microcap sector weakness compounded this, with no competitive wins or macro relief. Telecom demand held steady via Lifeline, but fintech inefficiencies and below-capacity operations eroded value. Cumulative impact: investor flight from unprofitable growth.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI trading bots from hundreds available, each scanning thousands of tickers across strategies like momentum, mean reversion, and scalping. These curated bots, filtered by recent win rates, Sharpe ratios, and relevance to market conditions, help investors automate trades with varying timeframes from intraday to swing. Neutral and data-driven, the section highlights metrics like average return and drawdown for transparency. Explore Trending AI Robots to enhance your stock analysis and discover bots tailored for volatile names like SURG.
SURG Stock Forecast Drivers: What Investors Should Watch Next
Investors should monitor the delayed Q4/full-year 2025 earnings call on April 14, 2026, for updates on 10-K filing, cash position, and $225M 2026 revenue guidance. Track MVNO growth in Lifeline/LinkUp amid government funding stability.
Fintech rollout progress, including stored value platform adoption and Clearline margins, will signal operational improvements. Macro trends like rural broadband demand and rate cuts could aid, but watch cash burn, dilution risks from offerings, and competition in prepaid services.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
SURG in upward trend: price may ascend as a result of having broken its lower Bollinger Band on June 12, 2026
SURG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where SURG's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for SURG's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SURG advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on June 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SURG as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for SURG turned negative on June 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SURG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for SURG entered a downward trend on June 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SURG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SURG's P/B Ratio (344.828) is very high in comparison to the industry average of (10.043). P/E Ratio (38.250) is within average values for comparable stocks, (31.574). Projected Growth (PEG Ratio) (0.474) is also within normal values, averaging (10.021). SURG has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.041). P/S Ratio (0.135) is also within normal values, averaging (6.667).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SURG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry MajorTelecommunications